SID 2026Abstract 0306
Early survival benefit of SARS-CoV-2 mRNA vaccination during immune checkpoint inhibitor therapy in cutaneous melanoma & squamous cell carcinoma
Mendez D, Hill MA, Guzman N, Arbesman J
SID Annual Meeting 2026Chicago, 13–16 May 2026 · published in JID 21 Jul 2026
Topics: Skin cancer & tumorsInfections & infestations
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/j.jid.2026.06.337 · Not in PubMed: details from Crossref